血小板減少與血液中微粒的臨床檢驗結(jié)果分析

打開文本圖片集

【摘要】目的：統(tǒng)計血小板減少與血液中微粒的臨床檢驗結(jié)果。方法：對2018年5月—2020年7月階段內(nèi)的血栓性疾病128例患者納入研究范圍，并且選取同期體檢的健康人員加以比較，檢測接受檢驗的人員血小板微粒情況，研究檢驗最終結(jié)果。結(jié)果：冠心病患者、腎功能衰竭患者、腦梗死患者這幾種疾病患者在處于靜息狀態(tài)下的血小板微粒釋放量均大于健康人員微粒釋放量（1.40±0.56）×105/mL（P0.05）；健康人員在活化狀態(tài)下微粒釋放量均數(shù)（1.82±0.50）×105/mL，較靜息狀態(tài)下微粒釋放量均數(shù)（1.40±0.74）×105/mL大（P

【關(guān)鍵詞】血小板；血液；微粒；臨床檢驗

Analysis of clinical test results of thrombocytopenia and particles in blood

LING Haiying

Wushan Hospital of traditional Chinese Medicine， Tianshui， Gansu 741306， China

【Abstract】Objective： to count the clinical test results of thrombocytopenia and particles in blood. Methods： 128 patients with thrombotic diseases from May 2018 to July 2020 were included in the study， and the healthy personnel who underwent physical examination in the same period were selected for comparison. The platelet particles of the personnel who underwent the examination were detected， and the final results were tested. Results： the release of platelet particles in patients with coronary heart disease， renal failure and cerebral infarction was greater than that in healthy people （1.40 ± 0.56）×105 /mL（P0.05）； The average amount of particles released by healthy people in activated state （1.82±0.50）×105/ mL，compared with the mean particle release under resting state（1.40±0.74）×105/mL（P

【Key words】Platelet； Blood； Particles； Clinical test

血小板是機(jī)體骨髓成熟的巨核細(xì)胞胞質(zhì)經(jīng)過裂解脫落的產(chǎn)物，還是哺乳動物血液內(nèi)生物活性的一種組成成分。（剩余3399字）